noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

NCGA - National Corn Growers[...]

National Corn Growers Association and Ag Data Transparent Release[...]
United States Attorney's Office[...]

Brazilian National Living in Yarmouth Sentenced for Selling Firearms[...]
Alector Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Barbara Ann Karmanos Cancer Institute

02/13/2026 | Press release | Archived content

IN THE NEWS - PATHFINDER Study: 4-Year Safety of Avapritinib for Patients with Advanced Systemic Mastocytosis

February 13, 2026

MD/alert

Suresh Balasubramanian, M.D., hematologist and medical oncologist, and member of the Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, discussed the latest survival data from the PATHFINDER study, investigating the use of the targeted inhibitor KIT D816V. He explained how this therapy has transformed the treatment of systemic mastocytosis.

Watch the interview here (scroll down to view).

Barbara Ann Karmanos Cancer Institute published this content on February 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 18, 2026 at 13:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format